Trademark Search  /  INGENOX

INGENOX

● Live · Registered

U.S. federal trademark · Serial No. 98015547 · Reg. No. UK00003854562

Mark
INGENOX
Status
Registered
Serial Number
98015547
Registration No.
UK00003854562
Filing Date
May 26, 2023
Registration Date
March 24, 2023
Class(es)
Class 005, Class 042

Owners

INGENOX THERAPEUTICS LIMITED
99 · Oxford, GB
INGENOX THERAPEUTICS LIMITED
99 · Oxford, GB
INGENOX THERAPEUTICS LIMITED
99 · Oxford, GB

Goods & Services

biochemical research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and/or cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; inhibitors of arginine methylation for the treatment of cancer; inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; compounds for the treatment, diagnosis, detection and/or prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "INGENOX" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.